A recent analysis of UK Biobank data suggests that greater amounts of moderate-to-vigorous physical activity (MVPA) are associated with lower risk of developing type 2 diabetes. The investigators compared participants grouped by MVPA volume and reported a hazard ratio (HR) of 2.07 for the lower-MVPA group versus the higher-MVPA group, indicating that lower activity was associated with roughly twice the adjusted rate of incident type 2 diabetes observed in the higher-activity group.
In the cohort, the higher-MVPA group accumulated a median of 409 minutes of MVPA per week; all participants in this group met the World Health Organization’s minimum recommendation of at least 150 minutes of moderate aerobic activity per week. The lower-MVPA group had a median of 121 minutes per week, and about 37% of that group reached the WHO recommendation. The study authors emphasize the association between greater MVPA volume and lower diabetes risk rather than establishing a causal relationship because the analysis is observational.
The research used data from almost 88,000 adults enrolled in the UK Biobank. The analysis categorized participants into higher- and lower-MVPA groups based on age-specific medians rather than applying an absolute threshold. The median weekly MVPA in the higher group was 409 minutes compared with 121 minutes in the lower group.
The authors reported that participants in the higher-MVPA group uniformly met WHO guidance of at least 150 minutes per week of moderate aerobic activity. The observed HR of 2.07 for the lower-MVPA versus higher-MVPA group reflects adjusted rates of incident type 2 diabetes in this sample.
Clinicians who commented on the study noted its observational design. Opel Baker, MBChB, observed that an HR of 2.07 is clinically meaningful but does not prove that low activity directly causes diabetes. David Cutler, MD, explained that the HR indicates the rate of developing diabetes was approximately twice as high in the lower-activity group after statistical adjustment.
Age modified the strength of the association between MVPA and diabetes risk. Among participants aged 62.7 years or younger, those with lower MVPA were 2.44 times more likely to develop type 2 diabetes compared with their higher-MVPA peers. For participants aged 62.7 years or older, the corresponding HR for lower versus higher MVPA was 1.65.
Experts cautioned that a lower relative HR in older adults does not imply exercise is less valuable with age. Cutler noted that although the relative association weakened, the absolute difference in diabetes incidence widened with age, making the clinical impact substantial in older populations. Baker emphasized that it is never too late to increase activity and that staying active across the lifespan is important because baseline diabetes risk rises with age.
The study authors reported that higher MVPA volume was associated with lower risk of progression to type 2 diabetes among people with prediabetes. Commentators framed exercise in prediabetes as a management strategy to improve insulin sensitivity and potentially return blood glucose toward the normal range, thereby reducing progression risk.
Baker advised that exercise prescriptions for people with prediabetes need not be fundamentally different from general guidance: begin with realistic, sustainable activity and build gradually according to fitness, comorbidities, and individual goals. He also highlighted the role of strength training, noting that maintaining and increasing muscle mass supports glucose disposal.
The study concentrated on the intensity and volume of MVPA rather than comparing exercise modalities. Experts recommended combining aerobic exercise (for example, brisk walking, cycling, swimming, jogging, hiking) with resistance training (weights, resistance machines, bands, or body-weight exercises) because skeletal muscle is a primary site of glucose disposal and improving muscle mass and insulin sensitivity has metabolic benefits.
Although the higher-MVPA group’s median of 409 minutes per week is descriptive of this cohort, clinicians warned against treating it as a prescriptive target. Baker underscored that the researchers defined higher and lower activity relative to age-specific medians; 409 minutes was not presented as a clinical threshold. For most adults, WHO guidance of 150–300 minutes of moderate aerobic activity weekly, combined with muscle-strengthening activities on at least two days, remains a sensible and achievable recommendation.
Commentators agreed the findings reinforce established clinical messages: physical activity is a powerful, accessible intervention to improve insulin sensitivity and reduce diabetes risk. Cutler summarized mechanistic benefits of regular exercise, including improved insulin sensitivity, reduced visceral fat, greater skeletal-muscle glucose uptake, and favorable effects on lipid metabolism.
Both commentators reminded readers that the study’s observational nature limits causal inference. Nevertheless, the association between higher MVPA and lower type 2 diabetes incidence—seen across age groups and present among people with prediabetes—supports promoting regular MVPA along with resistance training as part of diabetes prevention and management strategies.
The study details, quoted perspectives, and guideline comparisons reported here are derived from the published analysis and the clinicians’ comments included in the source article.